Search Results
Aug 11, 2026, 08:00 ET Sentynl Therapeutics and Mereo BioPharma Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)
Sentynl expands its rare disease portfolio with potential first-in-class oral treatment for AATD-LD, a rare genetic respiratory diseaseOn option exercise, Sentynl will have the right to commercialize the product in the United States; Mereo to lead global development
More news about: Sentynl Therapeutics
Aug 11, 2026, 08:00 ET OurCrowd Names Cali Chill Chief Executive Officer, Ushering in a New Era of Discipline and Rare Access
multimedia:https://www.prnewswire.com/news-releases/ourcrowd-names-cali-chill-chief-executive-officer-ushering-in-a-new-era-of-discipline-and-rare-access-302848291.htmlSOURCE
More news about: OurCrowd
Aug 11, 2026, 08:00 ET Kalohexis Appoints Life Sciences Leader, Jeffrey Sherman, MD, to Board of Directors
"Jeff is a distinguished industry leader who brings valuable experience in global clinical and regulatory strategy and rare disease drug development to Kalohexis' Board of Directors," said Russell Potterfield, Chief Executive Officer of Kalohexis. "We are thrilled to welcome
More news about: Kalohexis
Aug 11, 2026, 08:00 ET Novo Nordisk's Awiqli®, the first once-weekly basal insulin for adults with type 2 diabetes, now available in the US
heritage has given us experience and capabilities that also enable us to drive change to help people defeat other serious chronic diseases such as obesity, rare blood, and endocrine disorders. We remain steadfast in our conviction that the formula for lasting success is to stay focused, think long-term,
More news about: Novo Nordisk
Aug 11, 2026, 07:54 ET EQT Life Sciences participates in Vaderis Therapeutics' USD 152 million Series B financing
a Swiss clinical-stage biotechnology company developing targeted therapies for rare vascular diseases. Its lead program, engasertib, is being developed as a potential first treatment specifically developed for HHT, a rare inherited blood vessel disorder affecting ~1 in 3,800. HHT causes recurrent and
More news about: EQT
Aug 11, 2026, 07:50 ET SLENYTO® (melatonin extended-release tablets) is now available in Canada as a prescription treatment for insomnia in children and adolescents with autism spectrum disorder (ASD) and/or Smith-Magenis syndrome (SMS).
quality of life for both the child and the caregiver.7,8About Smith-Magenis Syndrome Smith-Magenis Syndrome (SMS) is a rare genetic disorder caused by a deletion or mutation involving the RAI1 gene on chromosome 17, characterized by distinctive physical features, developmental
More news about: Kye Pharmaceuticals Inc.
Aug 11, 2026, 07:30 ET Planet Green Enters the Fast Growing Global Lactoferrin Market, Adding Chief Scientist to Drive Innovation-Based Product Portfolio Growth
Company Gains Access to Rare and Commercially Desirable High-Quality Lactoferrin for the Large and Rapidly Scaling Chinese Markets, Adding New Scientist to Drive New Product Development NEW
More news about: Planet Green Holdings Corp.
Aug 11, 2026, 07:30 ET Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
events, including treatment-related adverse events that lead to death in 0.5% of patients.About SarcomaSoft tissue sarcoma is a rare type of cancer that starts with the growth of cells in the body's soft tissue, such as muscle, fat, blood vessels, nerves, tendons, and linings of the
More news about: Intensity Therapeutics Inc.
Aug 11, 2026, 07:07 ET CAPR Investor Announcement: Capricor Therapeutics Sued on behalf of Investors to Recover Losses after Clinical Data Leads to 64% Stock Drop
Sued for Securities Fraud? Capricor is a biotechnology company focused on developing cell and exosome-based therapeutics for rare diseases. Its lead product candidate, Deramiocel, is an investigational cell therapy being developed for Duchenne muscular dystrophy.According
More news about: Bleichmar Fonti & Auld LLP
Aug 11, 2026, 07:02 ET Double Good Earns Rare 19th Appearance on the Inc. 5000 List of America's Fastest-Growing Private Companies
content:https://www.prnewswire.com/news-releases/double-good-earns-rare-19th-appearance-on-the-inc-5000-list-of-americas-fastest-growing-private-companies-302847704.htmlSOURCE
More news about: Double Good
Aug 11, 2026, 07:02 ET Brkthru Celebrates Five Consecutive Years on Inc. 5000
Meta, Chobani, Oracle and Patagonia."Being named to the Inc. 5000 for a fifth consecutive year is an incredible honor and places Brkthru in a rare class of companies," said Brkthru Co-Founder and Managing Director Jeff Hastedt. "Very few companies achieve this milestone, and it's proof that the
More news about: Brkthru
Aug 11, 2026, 07:00 ET Vaderis Therapeutics Announces Oversubscribed $152 Million Series B Financing and Initiation of the Global Phase 3 HEROIC Study of Engasertib for Hereditary Hemorrhagic Telangiectasia
Aug. 11, 2026 /PRNewswire/ -- Vaderis Therapeutics, a clinical-stage biopharmaceutical company focused on developing targeted therapies for rare vascular diseases, today announced the closing of a private $152 million Series B financing and initiation of HEROIC, the company's global Phase 3 clinical
More news about: Vaderis Therapeutics AG
Aug 11, 2026, 07:00 ET Vaderis Therapeutics Announces Oversubscribed $152 Million Series B Financing and Initiation of the Global Phase 3 HEROIC Study of Engasertib for Hereditary Hemorrhagic Telangiectasia
Aug. 11, 2026 /PRNewswire/ -- Vaderis Therapeutics, a clinical-stage biopharmaceutical company focused on developing targeted therapies for rare vascular diseases, today announced the closing of a private $152 million Series B financing and initiation of HEROIC, the company's global Phase 3 clinical
More news about: Vaderis Therapeutics AG
Aug 11, 2026, 06:30 ET Keenova Reports Second Quarter 2026 Financial Results
KeenovaKeenova Therapeutics is a leading U.S.-focused branded therapeutics company that strives to help patients with rare or unaddressed conditions live happier and healthier lives.Keenova's rare disease capabilities underpin our diversified brands portfolio, which is focused across a wide range of specialty
More news about: Keenova Therapeutics
Aug 11, 2026, 06:01 ET ImagineX Named to 2026 Inc. 5000 List of America's Fastest-Growing Private Companies
that our growth is sustainable than I am right now," said Austin Curtis, Chief Operating Officer of ImagineX. "We have an amazing company culture and a rare set of talent, and that combination helps us drive world-class client satisfaction."For the complete Inc. 5000 list, visit
More news about: ImagineX
Aug 11, 2026, 01:34 ET LINDIAN verwerft resterend belang van 49 % en verkrijgt 100 % eigendom van de operationele hydrometallurgische faciliteit van SARECO
commerciële omvang buiten China, naast MP Materials Inc., Serra Verde en Lynas Rare Earths Ltd.MREC-verwerking gepland voor het vierde kwartaal van 2026 (in lijn met de eerste productie van het Kangankunde Rare Earths Project). Mogelijkheid om de verwerking eerder te starten dankzij potentiële
More news about: Lindian Resources
Aug 10, 2026, 16:37 ET HelloNation Article Featuring Electrical Expert Gerald Talbot Outlines How to Choose a Licensed Electrician You Can Trust
insured electrician should have current liability coverage and workers' compensation documentation. These protections reduce the homeowner's risk in the rare event that something goes wrong during the job. Electrical Expert Gerald Talbot agrees that transparency matters, and professionals in this field expect
More news about: HelloNation
Aug 10, 2026, 16:15 ET Construction Partners, Inc. Mourns the Passing of Michael McKay, Member of the Board of Directors
Mike brought extraordinary judgment, integrity and financial expertise to our Board, particularly through his leadership on the Audit Committee. His rare combination of experience in finance, industry and academia made him a trusted advisor whose counsel strengthened our governance and strategic decision-making.
More news about: Construction Partners, Inc.
Aug 10, 2026, 16:02 ET Biohaven Reports Recent Business Developments and Second Quarter 2026 Financial Results
clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases, today reported financial results for the second quarter ended June 30, 2026, and provided a review of recent accomplishments and
More news about: Biohaven Ltd.
Aug 10, 2026, 14:03 ET Legendary Celebrity Portrait Photographer Andy Gotts Debuts THE PLAYLIST, His First-Ever California Exhibition at Santa Barbara's El Encanto
The luxury resort unveils 40 large-format unretouched prints featuring titans of music, along with rare, co-signed works, including Dolly Parton, Ozzy Osbourne, Mick Fleetwood and moreSANTA BARBARA, Calif., Aug.
More news about: El Encanto
Aug 10, 2026, 13:00 ET NAHQ Strengthens Executive Leadership Team with Two Key Appointments to Accelerate Strategic Growth and Enterprise Readiness
lead complex organizational transformation and her proven success building alignment across the company."Tanya has consistently demonstrated the rare ability to pair strategic thinking with disciplined execution," Mercado said. "She brings clarity to complexity, makes thoughtful decisions grounded
More news about: National Association For Healthcare Quality
Aug 10, 2026, 12:53 ET LINDIAN ERWIRBT DIE VERBLEIBENDEN 49 % DER ANTEILE UND ERHÄLT DAMIT 100 % DER ANTEILE AN DER VON SARECO BETRIEBENEN HYDROMET-ANLAGE
fertiggestellte und in Betrieb befindliche MREC/CLP-Verarbeitungsanlage im kommerziellen Maßstab außerhalb Chinas, MP Materials Inc., Serra Verde und Lynas Rare Earths Ltd.Die MREC-Verarbeitung ist für das nächste Quartal, das 4. Quartal 2026, vorgesehen (im Einklang mit der ersten Produktion
More news about: Lindian Resources
Aug 10, 2026, 12:00 ET Lennar Celebrates Grand Opening of Hitching Post Farms in Madison, Alabama
"Hitching Post Farms gives homebuyers the rare combination of new construction close to major employers, highly ranked schools and some of North Alabama's best outdoor recreation," said Jayson Williams,
More news about: Lennar
Aug 10, 2026, 11:07 ET LINDIAN ACQUIERT LES 49 % RESTANTS POUR DÉTENIR 100 % DE L'USINE HYDROMÉTALLURGIQUE EN ACTIVITÉ DE SARECO
seule usine de traitement de MREC/CLP à échelle commerciale construite et en activité en dehors de la Chine, de MP Materials Inc., Serra Verde et Lynas Rare Earths Ltd.Le traitement MREC est prévu pour le quatrième trimestre de 2026 (conformément au lancement de la production du projet de
More news about: Lindian Resources
Aug 10, 2026, 09:53 ET GO FURTHER: NATIONAL GEOGRAPHIC-LINDBLAD EXPEDITIONS UNVEILS 2028-29 DEPLOYMENT
Pacific, including holiday departures in Antarctica, longer Arctic expeditions, river voyages through Europe, and a return to French Polynesia with rare access to Makatea, the only uplifted atoll in French Polynesia with sea cliffs, limestone caves, and a stalactite grotto that visitors can swim into.
More news about: National Geographic-Lindblad Expeditions